Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032

 2.3 Market Size & Forecast, By Segmentation, 2021–2032

  2.3.1 Market Size By Mode

  2.3.2 Market Size By Application

         2.3.2 Market Size By Method

         2.3.2 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2024

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1. Incidence and Prevalence (2024)
 4.1.1. Prevalence of Genetic Disorders Requiring Gene Therapy
 4.1.2. Incidence of Chronic Diseases Driving Non-Viral Delivery Research
 4.1.3. Rise in Cancer and Rare Diseases: Key Target for Non-Viral Gene Delivery
 4.1.4. Regional Distribution of Relevant Disease Burden (North America, Europe, Asia Pacific, etc.)

4.2. Research and Clinical Trial Trends (2024)
 4.2.1. Number of Ongoing Preclinical and Clinical Trials Involving Non-Viral Vectors
 4.2.2. Publications and Research Output by Region
 4.2.3. Government and Academic Funding Trends
 4.2.4. Institutional Collaborations and Innovation Hubs

4.3. Technology Adoption and Volume Trends (2020–2032)
 4.3.1. Device and Technology Adoption Volume, by Year
 4.3.2. Comparison Between Non-Viral and Viral Vector Usage Trends
 4.3.3. Volume Share, by Application (Research, Therapeutics)
 4.3.4. Growth in Ex Vivo vs. In Vivo vs. In Vitro Delivery Method Usage

4.4. Healthcare and R&D Spending, by Region (2024)
 4.4.1. Government Healthcare Expenditure in Gene Delivery Research
 4.4.2. Private Sector and Biotech Investment in Non-Viral Technologies
 4.4.3. Out-of-Pocket Spending on Gene-Based Therapeutics (Patient Perspective)

 5. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By Mode, 2021 – 2032, Value (USD Billion)

5.1 Introduction

 5.2 Chemical

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2021 – 2032

5.2.3 LNPs

5.2.4 Polymers

5.2.5Others

 5.3 Physical

5.3.3 Electroporation

5.3.5 Microinjection

5.3.5 Others

 6. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)

    6.1 Introduction

 6.2 Research

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2021 – 2032

 6.3.3 Therapeutics

 6.3.4 Gene Therapy

 6.3.5 Cell Therapy

 6.3.6 Vaccines

 7. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By Method, 2021 – 2032, Value (USD Billion)

    7.1 Introduction

 7.2 Ex Vivo

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2021 – 2032

 7.3 In Vivo

 7.4 In Vitro

 8. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By End Use, 2021 – 2032, Value (USD Billion)

    8.1 Introduction

 8.2 Biotechnology and Biopharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2021 – 2032

 8.3 Research and Academic Institutes

 8.4 Others

9. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2021 – 2032

 9.2.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2021 – 2032

 9.2.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2021 – 2032

 9.2.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2021 – 2032

 9.2.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2021 – 2032

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2021 – 2032

 9.3.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2021 – 2032

 9.3.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2021 – 2032

 9.3.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2021 – 2032

 9.3.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2021 – 2032

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2021 – 2032

 9.4.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2021 – 2032

 9.4.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2021 – 2032

 9.4.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2021 – 2032

 9.4.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2021 – 2032

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2021 – 2032

 9.5.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2021 – 2032

 9.5.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2021 – 2032

 9.5.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2021 – 2032

 9.5.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2021 – 2032

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2021 – 2032

 9.6.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2021 – 2032

 9.6.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2021 – 2032

 9.6.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2021 – 2032

 9.6.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2021 – 2032

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2024

  10.2.2 Year-Wise Strategies & Development, 2021 – 2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2024

 10.3 Market Share Analysis, 2024

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

10.6 Key Company Profiles

 10.6.1 Polyplus-transfection SA
  10.6.1.1 Company Overview & Snapshot
  10.6.1.2 Product/Service Portfolio
  10.6.1.3 Key Company Financials
  10.6.1.4 SWOT Analysis

 10.6.2 Mirus Bio LLC

 10.6.3 Altogen Biosystems

 10.6.4 SignaGen Laboratories

 10.6.5 OZ Biosciences

 10.6.6 MaxCyte Inc.

 10.6.7 IBA GmbH

 10.6.8 Thermo Fisher Scientific

 10.6.9 Merck KGaA

 10.6.10 QIAGEN N.V.

 10.6.11 Takara Bio Inc.

 10.6.12 Biontex Laboratories GmbH

 10.6.13 Promega Corporation

 10.6.14 Bio-Rad Laboratories Inc.

 10.6.15 GenScript Biotech Corporation

 10.6.16 Lonza Group AG

 10.6.17 Agilent Technologies Inc.

 10.6.18 EMD Millipore

 10.6.19 OriGene Technologies Inc.

 10.6.20 Bio-Techne Corporation

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures